Transmissible spongiform encephalopathy historical perspective
|
Transmissible spongiform encephalopathy Microchapters |
|
Differentiating Transmissible spongiform encephalopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Transmissible spongiform encephalopathy historical perspective On the Web |
|
American Roentgen Ray Society Images of Transmissible spongiform encephalopathy historical perspective |
|
FDA on Transmissible spongiform encephalopathy historical perspective |
|
CDC on Transmissible spongiform encephalopathy historical perspective |
|
Transmissible spongiform encephalopathy historical perspective in the news |
|
Blogs on Transmissible spongiform encephalopathy historical perspective |
|
Directions to Hospitals Treating Transmissible spongiform encephalopathy |
|
Risk calculators and risk factors for Transmissible spongiform encephalopathy historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rinky Agnes Botleroo, M.B.B.S.
Overview
Prion diseases are a group of neurodegenerative disorders which include Kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker (GSS) syndrome, and fatal familial insomnia in men, natural scrapie in sheep and goats, transmissible mink encephalopathy in ranch-reared mink, chronic wasting disease of mule deer, Bovine Spongiform Encephalopathy or "Mad Cow disease".Scarpie was fiirst described in 1732.In 1957, the first prion disease in humans, Kuru was described and its transmissibility was demonstrated in 1965 by Gajdusek, Gibbs and colleagues.They also described the transmission of Creutzfeldt-Jakob disease (CJD) and Gerstmann-Sträussler-Scheinker. In 1982, Stanley B. Prusiner presented "prion hypothesis" which describes that a misfolded protein is responsible for prion diseases.
Historical Perspective
- Natural Scrapie[1] is a infection that affects sheep and it is caused by an unknown infectious agent.
- It was first described in 1732.
- Kuru is the first prion disease in humans which was described in 1957.It is a fatal neurodegenerative disease that affected only people of a single language group in the remote mountainous interior of New Guinea.
- In 1959, veterinary pathologist W.J. Hadlow first described several similarities between Scrapie and Kuru.
- In 1959, I. Klatzo also recognized that Kuru's histopathology was similar to that of Creutzfeldt-Jakob disease (CJD).
- Creutzfeldt-Jakob disease (CJD) is another neurodegenerative progressive disease of unknown etiology that A.M. Jakob had first described in 1921.[2]It is fatal.
- Gajdusek, C.J. Gibbs, Jr., and M.P. Alpers used the existing knowledge of Scrapie and started trials to transmit Kuru by inoculating Kuru brain tissue into non-human primates, It took them several years but finally they became successful in 1965.
- Later Gajdusek and his colleagues went on to demonstrate that not only the more common sporadic form of Creutzfeldt-Jakob disease (CJD) but also familial Creutzfeldt-Jakob disease (CJD) and a generally similar familial brain disease (Gerstmann-Sträussler-Scheinker syndrome) were also transmissible, first to non-human primates and later to other animals.[2]
- In 1982, [1]Stanley B. Prusiner presented "prion hypothesis". Prusiner discovered that a misfolded form of a ubiquitous normal host protein was usually but not all the time was detectable in tissues containing TSE agents.These misfolded proteins greatly facilitates the diagnosis and also helps in understanding their pathogenesis.
- Prusiner also said that the TSE agent was likely to be composed parially of the abnormal protein, for which he used the term "prion" protein and "prion" for the agent. Expression of the prion protein by animals-while not essential for life-was later found to be compulsory to infect them with TSEs
References
- ↑ 1.0 1.1 Liberski PP (2012). "Historical overview of prion diseases: a view from afar". Folia Neuropathol. 50 (1): 1–12. PMID 22505359.
- ↑ 2.0 2.1 Asher DM, Gregori L (2018). "Human transmissible spongiform encephalopathies: historic view". Handb Clin Neurol. 153: 1–17. doi:10.1016/B978-0-444-63945-5.00001-5. PMID 29887130.